These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12610740)

  • 1. Effect of ciprofloxacin on the pharmacokinetics of ropivacaine.
    Jokinen MJ; Olkkola KT; Ahonen J; Neuvonen PJ
    Eur J Clin Pharmacol; 2003 Feb; 58(10):653-7. PubMed ID: 12610740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: an interaction study with fluvoxamine and ketoconazole as in vivo inhibitors.
    Arlander E; Ekström G; Alm C; Carrillo JA; Bielenstein M; Böttiger Y; Bertilsson L; Gustafsson LL
    Clin Pharmacol Ther; 1998 Nov; 64(5):484-91. PubMed ID: 9834040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rifampin and tobacco smoking on the pharmacokinetics of ropivacaine.
    Jokinen MJ; Olkkola KT; Ahonen J; Neuvonen PJ
    Clin Pharmacol Ther; 2001 Oct; 70(4):344-50. PubMed ID: 11673750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of erythromycin, fluvoxamine, and their combination on the pharmacokinetics of ropivacaine.
    Jokinen MJ; Ahonen J; Neuvonen PJ; Olkkola KT
    Anesth Analg; 2000 Nov; 91(5):1207-12. PubMed ID: 11049910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of clarithromycin and itraconazole on the pharmacokinetics of ropivacaine.
    Jokinen MJ; Ahonen J; Neuvonen PJ; Olkkola KT
    Pharmacol Toxicol; 2001 Apr; 88(4):187-91. PubMed ID: 11322176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of ropivacaine in uremic and nonuremic patients after axillary brachial plexus block.
    Pere P; Salonen M; Jokinen M; Rosenberg PH; Neuvonen PJ; Haasio J
    Anesth Analg; 2003 Feb; 96(2):563-9, table of contents. PubMed ID: 12538213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of a new local anesthetic, ropivacaine, by human hepatic cytochrome P450.
    Oda Y; Furuichi K; Tanaka K; Hiroi T; Imaoka S; Asada A; Fujimori M; Funae Y
    Anesthesiology; 1995 Jan; 82(1):214-20. PubMed ID: 7832304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and excretion of ropivacaine in humans.
    Halldin MM; Bredberg E; Angelin B; Arvidsson T; Askemark Y; Elofsson S; Widman M
    Drug Metab Dispos; 1996 Sep; 24(9):962-8. PubMed ID: 8886605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional transport and metabolism of ropivacaine and its CYP3A4 metabolite PPX in human intestine.
    Berggren S; Lennernäs P; Ekelund M; Weström B; Hoogstraate J; Lennernäs H
    J Pharm Pharmacol; 2003 Jul; 55(7):963-72. PubMed ID: 12906753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of ropivacaine in patients with chronic renal failure.
    Pere PJ; Ekstrand A; Salonen M; Honkanen E; Sjövall J; Henriksson J; Rosenberg PH
    Br J Anaesth; 2011 Apr; 106(4):512-21. PubMed ID: 21307007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparison of Differences Between the Systemic Pharmacokinetics of Levobupivacaine and Ropivacaine During Continuous Epidural Infusion: A Prospective, Randomized, Multicenter, Double-Blind Controlled Trial.
    Perotti L; Cusato M; Ingelmo P; Niebel TL; Somaini M; Riva F; Tinelli C; De Andrés J; Fanelli G; Braschi A; Regazzi M; Allegri M
    Anesth Analg; 2015 Aug; 121(2):348-56. PubMed ID: 25977992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes.
    Ekström G; Gunnarsson UB
    Drug Metab Dispos; 1996 Sep; 24(9):955-61. PubMed ID: 8886604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of premedication medicines on the formation of the CYP3A4-dependent metabolite of ropivacaine, 2', 6'-Pipecoloxylidide, on human liver microsomes in vitro.
    Tanaka E; Nakamura T; Inomata S; Honda K
    Basic Clin Pharmacol Toxicol; 2006 Feb; 98(2):181-3. PubMed ID: 16445592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of three doses of epidural ropivacaine during hysterectomy and comparison with bupivacaine.
    Sandler AN; Arlander E; Finucane BT; Taddio A; Chan V; Milner A; Callahan-Enright SO; Friedlander M; Muzyka D
    Can J Anaesth; 1998 Sep; 45(9):843-9. PubMed ID: 9818106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetic analysis of ropivacaine and its metabolite 2',6'-pipecoloxylidide from pooled data in neonates, infants, and children.
    Aarons L; Sadler B; Pitsiu M; Sjövall J; Henriksson J; Molnár V
    Br J Anaesth; 2011 Sep; 107(3):409-24. PubMed ID: 21693469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ciprofloxin on the pharmacokinetics of intravenous lidocaine.
    Isohanni MH; Ahonen J; Neuvonen PJ; Olkkola KT
    Eur J Anaesthesiol; 2005 Oct; 22(10):795-9. PubMed ID: 16211753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of ropivacaine in patients with chronic end-stage liver disease.
    Jokinen MJ; Neuvonen PJ; Lindgren L; Höckerstedt K; Sjövall J; Breuer O; Askemark Y; Ahonen J; Olkkola KT
    Anesthesiology; 2007 Jan; 106(1):43-55. PubMed ID: 17197844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatographic determination of ropivacaine, 3-hydroxy-ropivacaine, 4-hydroxy-ropivacaine and 2',6'-pipecoloxylidide in plasma.
    Reif S; Le Corre P; Dollo G; Chevanne F; Le Verge R
    J Chromatogr B Biomed Sci Appl; 1998 Nov; 719(1-2):239-44. PubMed ID: 9869387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliposomal Ropivacaine Oil: Pharmacokinetic and Pharmacodynamic Data After Subcutaneous Administration in Volunteers.
    Ginosar Y; Haroutounian S; Kagan L; Naveh M; Aharon A; Davidson EM
    Anesth Analg; 2016 May; 122(5):1673-80. PubMed ID: 27057798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism.
    Granfors MT; Backman JT; Neuvonen M; Neuvonen PJ
    Clin Pharmacol Ther; 2004 Dec; 76(6):598-606. PubMed ID: 15592331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.